XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure        
Net loss attributable to Arrowhead Pharmaceuticals, Inc. $ (170,793) $ (102,946) $ (428,957) $ (95,596)